« Back to news listing

MiCardia Corporation Completes Financing and Spin-off of its Transcatheter Technology to a New Cardiovascular Company, ValCare, Inc.

MiCardia Corporation, announced today that it had completed an internal round of funding. MiCardia plans to use the proceeds of this funding to expand the commercialization of its enCorSQ Mitral Valve Repair System(TM) in Europe and select countries worldwide.

Read entire article: http://www.marketwatch.com/story/micardia-corporation-completes-financing-and-spin-off-of-its-transcatheter-technology-to-a-new-cardiovascular-company-valcare-inc-2012-07-10

« Back to news listing